| Host: | CHO cells |
| Applications: | ELISA |
| Reactivity: | SARS-CoV-2 |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Cho Cells monoclonal antibody anti-Recombinant-SARS-CoV-2 Spike RBD is suitable for use in ELISA research applications. |
| Clonality : | Monoclonal |
| Clone ID : | 79C3 |
| Conjugation: | Unconjugated |
| Isotype: | IgG kappa |
| Formulation: | PBS pH 7.4 |
| Purification: | Protein A affinity chromatography following gel filtration |
| Dilution Range: | Indirect ELISA 0.01 – 0.02 ng/ml |
| Storage Instruction: | The product is stable at 4 °C for several days. Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles. |
| Dissociation Constant: | <1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein) 6.9 x 10-9 M (measured against SARS-CoV-2 Spike S1 protein) |
| Specificity: | SARS-CoV-2 Spike RBD Neutralizing properties: blocks S1 and ACE2 binding in Octet system. |
| Immunogen: | Recombinant SARS-CoV-2 RBD protein produced by CHO-based proprietary suspension cell line. |